98%
921
2 minutes
20
Assessing hippocampal pathology in epilepsy is challenging, and improving diagnostic accuracy can benefit from deep learning image reconstruction, standardized imaging protocols, and advanced post-processing methods. This study compares T2 TSE DRB (Deep Resolve Boost) sequences with standard T2 TSE sequences for hippocampal segmentation and volumetry using FreeSurfer, focusing on how DRB affects image acquisition time without compromising diagnostic accuracy. FreeSurfer (version 7.4.1) was used to segment hippocampal subregions in 36 subjects (mean age of 39 ± 14 years; 21 males, 15 females) using both T2 TSE DRB and T2 TSE sequences. The segmented volumes were compared with a two-tailed -test, and pathological volume differences were assessed using z-values based on a 95% confidence interval (-2 < z < 2). Overall hippocampal segment volumes were identical between sequences. However, significant volume differences were noted in the CA1-Body ( = 0.003), CA4-Body ( = 0.002), and whole hippocampal body ( = 0.012) in the right hippocampus. Despite these differences, the low effect sizes suggest DRB sequences are comparable to conventional sequences. Additionally, DRB reduced image acquisition time by 61%. Z-scores identified pathological volume changes between the left and right hippocampus in individual subjects. T2 TSE DRB sequences are non-inferior to conventional T2 TSE sequences for hippocampal segmentation. The DRB method improves efficiency while providing clinically reliable results, and the proposed 95% confidence interval can aid in more objective assessments of hippocampal pathology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12192064 | PMC |
http://dx.doi.org/10.3390/diagnostics15121523 | DOI Listing |
Diagnostics (Basel)
June 2025
Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, 72076 Tübingen, Germany.
Assessing hippocampal pathology in epilepsy is challenging, and improving diagnostic accuracy can benefit from deep learning image reconstruction, standardized imaging protocols, and advanced post-processing methods. This study compares T2 TSE DRB (Deep Resolve Boost) sequences with standard T2 TSE sequences for hippocampal segmentation and volumetry using FreeSurfer, focusing on how DRB affects image acquisition time without compromising diagnostic accuracy. FreeSurfer (version 7.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
May 2025
Vir Biotechnology Inc., San Francisco, CA 94158.
Respiratory viruses represent a major global health burden. Although these viruses have different life cycles, they may depend on common host genetic factors, which could be targeted by broad-spectrum host-directed therapies. We used genome-wide CRISPR screens and advanced data analytics to map a network of host genes that support infection by nine human respiratory viruses [influenza A virus, parainfluenza virus, human rhinovirus, respiratory syncytial virus, human coronavirus (HCoV)-229E, HCoV-NL63, HCoV-OC43, Middle East respiratory syndrome-related coronavirus, and severe acute respiratory syndrome-related coronavirus 2].
View Article and Find Full Text PDFImmunity
March 2023
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against novel pandemic coronaviruses and to more effectively respond to SARS-CoV-2 variants. The emergence of Omicron and subvariants of SARS-CoV-2 illustrates the limitations of solely targeting the receptor-binding domain (RBD) of the spike (S) protein. Here, we isolated a large panel of broadly neutralizing antibodies (bnAbs) from SARS-CoV-2 recovered-vaccinated donors, which targets a conserved S2 region in the betacoronavirus spike fusion machinery.
View Article and Find Full Text PDFNat Immunol
June 2022
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
The emergence of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy. Development of broadly effective coronavirus vaccines that can mitigate these threats is needed. Here, we utilized a targeted donor selection strategy to isolate a large panel of human broadly neutralizing antibodies (bnAbs) to sarbecoviruses.
View Article and Find Full Text PDFbioRxiv
March 2022
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against coronaviruses that cause severe disease, for anticipating novel pandemic-causing viruses, and to respond more effectively to SARS-CoV-2 variants. The emergence of the Omicron variant of SARS-CoV-2 has illustrated the limitations of solely targeting the receptor binding domain (RBD) of the envelope Spike (S)-protein. Here, we isolated a large panel of broadly neutralizing antibodies (bnAbs) from SARS-CoV-2 recovered-vaccinated donors that target a conserved S2 region in the fusion machinery on betacoronavirus spikes.
View Article and Find Full Text PDF